Bio-Techne (TECH) Current Assets (2009 - 2026)

Bio-Techne's Current Assets history runs 18 years deep, the most recent figure standing at $688.0 million for Q1 2026.

• In Q1 2026, Current Assets rose 9.69% year-over-year to $688.0 million; the TTM figure through Mar 2026 stood at $688.0 million (up 9.69% YoY), while the FY2025 annual figure was $608.3 million, down 1.48% from the prior year.
• Current Assets for Q1 2026 stood at $688.0 million, up from $637.4 million in the prior quarter.
• The five-year high for Current Assets was $688.0 million in Q1 2026, with the low at $552.0 million in Q3 2022.
• The 5-year median for Current Assets is $609.5 million (2025), against an average of $610.1 million.
• The sharpest annual moves came in 2022 and 2025: Current Assets climbed 18.6% in 2022, then retreated 6.02% in 2025.
• Bio-Techne's Current Assets stood at $565.2 million in 2022, then climbed by 4.5% to $590.6 million in 2023, then grew by 7.45% to $634.6 million in 2024, then gained by 0.44% to $637.4 million in 2025, then rose by 7.94% to $688.0 million in 2026.
• Business Quant data shows TECH's Current Assets at $688.0 million in Q1 2026, $637.4 million in Q4 2025, and $609.5 million in Q3 2025.